clinical trials

Johnson & Johnson's Tremfya backs psoriatic arthritis play with newest data
Johnson & Johnson's Tremfya backs psoriatic arthritis play with newest data
Fierce Pharma
JNJ
Tremfya
psoriatic arthritis
psoriasis
clinical trials
Flag link:
Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity
Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity
Stat
Solid Biosciences
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
SGT-001
Flag link:
Safety qualms in MyoKardia mid-stage study cause investors to pause
Safety qualms in MyoKardia mid-stage study cause investors to pause
Endpoints
MyoKardia
obstructive hypertrophic cardiomyopathy
clinical trials
mavacamten
Flag link:
Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study
Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study
Endpoints
Roche
monoclonal antibodies
Gazyva
lupus
kidney disease
clinical trials
Flag link:
Regenxbio sues FDA over gene therapy clinical hold
Regenxbio sues FDA over gene therapy clinical hold
Fierce Biotech
Regenxbio
FDA
clinical hold
gene therapy
clinical trials
Flag link:
Aslan's latest cancer focus also flops, leaving just two major programs for the troubled biotech
Aslan's latest cancer focus also flops, leaving just two major programs for the troubled biotech
Endpoints
Aslan
biliary tract cancer
clinical trials
gastic cancer
varlitinib
Flag link:
A Look at America’s First CRISPR Clinical Trial
A Look at America’s First CRISPR Clinical Trial
Xtalks
CRISPR
gene editing
clinical trials
Flag link:
Nektar shows durability of Opdivo combo in 18-month update
Nektar shows durability of Opdivo combo in 18-month update
Fierce Biotech
Nektar Therapeutics
NKTR-214
Opdivo
Bristol-Myers Squibb
melanoma
clinical trials
Flag link:
Roche sets sights on Novartis, Biogen as SMA trial hits target
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Roche
SMA
risdiplam
Biogen
Novartis
clinical trials
Flag link:
AASLD: Gilead wants to move the needle for fatty liver therapies
AASLD: Gilead wants to move the needle for fatty liver therapies
Fierce Biotech
Gilead Sciences
NASH
selonsertib
clinical trials
AASLD
Flag link:
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Fierce Biotech
Bolt Biotherapeutics
immuno-oncology
clinical trials
cancer
Flag link:
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
Flag link:
AnaptysBio shares collapse after 'worst case scenario' for key drug
AnaptysBio shares collapse after 'worst case scenario' for key drug
Biopharma Dive
AnaptysBio
etokimab
clinical trials
Flag link:
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Fierce Pharma
Takeda
Ninlaro
Multiple Myeloma
clinical trials
Flag link:
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Flag link:
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Daiichi Sankyo
Exelixis
clinical trials
diabetic nephropathy
Minnebro
Flag link:
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Motley Fool
Seattle Genetics
breast cancer
advanced breast cancer
clinical trials
tucatinib
Flag link:
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Endpoints
Takeda
vaccines
dengue
clinical trials
Flag link:
Takeda's dengue shot 80% effective in massive phase 3 test
Takeda's dengue shot 80% effective in massive phase 3 test
Fierce Pharma
Takeda
dengue
vaccines
Sanofi
clinical trials
Flag link:
Tardy marketing application filing, trial failure troubles Supernus investors
Tardy marketing application filing, trial failure troubles Supernus investors
Endpoints
Supernus
earnings
ADHD
SPN-812
SPN-810
clinical trials
Flag link:

Pages